Adage Capital Partners Gp, L.L.C. Corcept Therapeutics Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 96,172 shares of CORT stock, worth $8.69 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
96,172Holding current value
$8.69 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
468Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.49 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$874 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$698 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$566 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$350 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $9.67B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...